Finzati - Logo
LH logo

Labcorp Holdings Inc.

LHMedical - Diagnostics & Research
$0.00
0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$25.96B
Growth
8.6%
Cash Flow
5/5
Trend
Stable
Evidence
Positive revenue growth · 5.4%Positive free cash flow · 14.5Consistent free cash flow · 5/5Manageable debt level · 0.84Healthy liquidity · 1.42
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 12:20 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$25.96B
52W Range244.52 - 317.10
Beta0.86
Gross Margin26.75%
Oper. Margin10.87%
Profit Margin6.28%
Debt/Eq0.84
Current Ratio1.42
Quick Ratio1.23
Revenue 5Y8.60%

Investment DNA

How strong this company looks for long-term investors

65
out of 100
Business Quality
Margins, moat, returns
44/100
Financial Strength
Debt, cash, stability
75/100
Growth Potential
Revenue and expansion
46/100
Price Attractiveness
Cheap or expensive today
75/100
Why this score
Positive revenue growth · 5.4%Positive free cash flow · 14.5Consistent free cash flow · 5/5Manageable debt level · 0.84Healthy liquidity · 1.42

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$300.00
Mean
$319.33
Median
$313.00
High
$352.00

Company Overview

IPO: 3/29/1990
Industry: Medical - Diagnostics & Research
P/B i: 2.42
Debt / Equity i: 0.84
Operating Margin: 10.87%
Net Margin: 6.28%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.84
Current Ratio: 1.42
Quick Ratio: 1.23
Status: Good

Insider Transactions

Recent executive and insider activity

Summy Amy B.
Transaction: 08/04/2026
SELL
Change
-924
Price
$306.74
Filing
08/06/2026
Type
SELL
Wilkinson Peter J
Transaction: 08/03/2026
SELL
Change
-1,338
Price
$209.25
Filing
08/05/2026
Type
SELL
Wilkinson Peter J
Transaction: 08/03/2026
SELL
Change
-1,338
Price
$309.23
Filing
08/05/2026
Type
SELL